GC
Globeflex Capital’s Bristol-Myers Squibb BMY Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $27.9M | Hold |
602,224
| – | – | 2.31% | 9 |
|
|
2025
Q1 | $36.7M | Hold |
602,224
| – | – | 3.39% | 2 |
|
|
2024
Q4 | $34.1M | Buy |
+602,224
| New | +$34.1M | 2.89% | 4 |
|
|
2021
Q4 | – | Sell |
-33
| Closed | -$2K | – | 466 |
|
|
2021
Q3 | $2K | Hold |
33
| – | – | ﹤0.01% | 437 |
|
|
2021
Q2 | $2K | Hold |
33
| – | – | ﹤0.01% | 442 |
|
|
2021
Q1 | $2K | Hold |
33
| – | – | ﹤0.01% | 438 |
|
|
2020
Q4 | $2K | Hold |
33
| – | – | ﹤0.01% | 452 |
|
|
2020
Q3 | $2K | Hold |
33
| – | – | ﹤0.01% | 448 |
|
|
2020
Q2 | $2K | Hold |
33
| – | – | ﹤0.01% | 472 |
|
|
2020
Q1 | $2K | Hold |
33
| – | – | ﹤0.01% | 476 |
|
|
2019
Q4 | $2K | Hold |
33
| – | – | ﹤0.01% | 477 |
|
|
2019
Q3 | $2K | Hold |
33
| – | – | ﹤0.01% | 465 |
|
|
2019
Q2 | $1K | Buy |
+33
| New | +$1K | ﹤0.01% | 498 |
|